Sandell Jacquelyn Fahey is Chief Legal Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 123,143 shares of VYGR, which is worth approximately $507,349. The most recent transaction as insider was on Feb 21, 2025, when has been sold 41,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
43.19% 3M change
33.85% 12M change
Total Value Held $507,349

Sandell Jacquelyn Fahey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2025
BUY
Grant, award, or other acquisition
-
41,500 Added 25.21%
123,143 Common Stock
Feb 11 2025
SELL
Open market or private sale
$19,393 $4.45 p/Share
4,358 Reduced 5.07%
81,643 Common Stock
Oct 02 2024
SELL
Open market or private sale
$34,914 $5.82 p/Share
5,999 Reduced 6.52%
86,001 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
31,000 Added 25.2%
92,000 Common Stock
Oct 01 2023
BUY
Grant, award, or other acquisition
-
61,000 Added 50.0%
61,000 Common Stock
SJF

Sandell Jacquelyn Fahey

Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR